Can the Results of the European Randomized Study of Screening for Prostate Cancer Be Decontaminated?

被引：1
|
作者：
Metcalfe, Chris [1 ]
机构：
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
来源：
EUROPEAN UROLOGY | 2014年 / 65卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2013.08.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：337 / 338
页数：2
相关论文
共 50 条
  • [41] Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Herault
    Jegu, J.
    Tretarre, B.
    Grosclaude, P.
    Rebillard, X.
    Bataille, V.
    Malavaud, B.
    Iborra, F.
    Salama, G.
    Rischmann, P.
    Villers, A.
    PROGRES EN UROLOGIE, 2009, 19 (07): : 487 - 498
  • [42] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Schroder, Fritz H.
    Hugosson, Jonas
    Carlsson, Sigrid
    Tammela, Teuvo
    Maattanen, Liisa
    Auvinen, Anssi
    Kwiatkowski, Maciej
    Recker, Franz
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2012, 62 (05) : 745 - 752
  • [43] Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
    de Vos, Ivo I.
    Remmers, Sebastiaan
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2024, 85 (01) : 74 - 81
  • [44] PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    Otto, S. J.
    Moss, S. M.
    Maattanen, L.
    Roobol, M.
    Zappa, M.
    Nelen, V.
    Kwiatkowski, M.
    Villers, A.
    Hugosson, J.
    Sanchez, A. Berenguer
    de Koning, H. J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3053 - 3060
  • [45] A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: Data from the European randomized study of prostate cancer screening (ERSPC) in Goteborg, Sweden
    Vickers, Andrew J.
    Cronin, Angel M.
    Aus, Gunnar
    Pihl, Carl G.
    Becker, Charlotte
    Pettersson, Kim
    Scardino, Peter T.
    Hugosson, Jonas
    Lilja, Hans
    JOURNAL OF UROLOGY, 2008, 179 (04) : 719 - 719
  • [46] A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
    Andrew J Vickers
    Angel M Cronin
    Gunnar Aus
    Carl-Gustav Pihl
    Charlotte Becker
    Kim Pettersson
    Peter T Scardino
    Jonas Hugosson
    Hans Lilja
    BMC Medicine, 6
  • [47] Prostate-specific antigen change in the European Randomized Study of screening for prostate cancer, section Rotterdam
    Raaijmakers, R
    Wildhagen, MF
    Ito, K
    Pàez, A
    De Vries, SH
    Roobol, MJ
    Schröder, FH
    UROLOGY, 2004, 63 (02) : 316 - 320
  • [48] Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region)
    Kranse, R
    Beemsterboer, P
    Rietbergen, J
    Habbema, D
    Hugosson, J
    Schröder, FH
    PROSTATE, 1999, 39 (04) : 316 - 322
  • [49] Effective PSA contamination in the Rotterdam section of the European randomized study of screening for prostate cancer
    Otto, SJ
    van der Cruijsen, IW
    Liem, MK
    Korfage, IJ
    Lous, JJ
    Schröder, FH
    de Koning, HJ
    INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (03) : 394 - 399
  • [50] The use of European Randomized study of Screening for Prostate Cancer calculator as a diagnostic tool for prostate biopsy indication
    Breza, J.
    Subin, F.
    Bernadic, M.
    Tomas, M.
    Pindak, D.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2019, 120 (05): : 331 - 335
12345